Literature DB >> 24189294

KRas(G12D)-evoked leukemogenesis does not require β-catenin.

C E L Ng1, A Sinha, A Krivtsov, S Dias1, J Chang, S A Armstrong1, D Kalaitzidis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24189294      PMCID： PMC4367949          DOI： 10.1038/leu.2013.328

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.

Authors:  A V Krivtsov; M E Figueroa; A U Sinha; M C Stubbs; Z Feng; P J M Valk; R Delwel; K Döhner; L Bullinger; A L Kung; A M Melnick; S A Armstrong
Journal:  Leukemia       Date:  2012-12-13       Impact factor: 11.528

2.  The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.

Authors:  Yingzi Wang; Andrei V Krivtsov; Amit U Sinha; Trista E North; Wolfram Goessling; Zhaohui Feng; Leonard I Zon; Scott A Armstrong
Journal:  Science       Date:  2010-03-26       Impact factor: 47.728

3.  Modulation of hematopoietic stem cell homing and engraftment by CD26.

Authors:  Kent W Christopherson; Giao Hangoc; Charlie R Mantel; Hal E Broxmeyer
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

4.  Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.

Authors:  Chen Zhao; Jordan Blum; Alan Chen; Hyog Young Kwon; Seung Hye Jung; J Michael Cook; Anand Lagoo; Tannishtha Reya
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

5.  Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.

Authors:  Iris T Chan; Jeffery L Kutok; Ifor R Williams; Sarah Cohen; Lauren Kelly; Hirokazu Shigematsu; Leisa Johnson; Koichi Akashi; David A Tuveson; Tyler Jacks; D Gary Gilliland
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

6.  Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.

Authors:  Wei Guo; Joseph L Lasky; Chun-Ju Chang; Sherly Mosessian; Xiaoman Lewis; Yun Xiao; Jennifer E Yeh; James Y Chen; M Luisa Iruela-Arispe; Marileila Varella-Garcia; Hong Wu
Journal:  Nature       Date:  2008-05-07       Impact factor: 49.962

7.  Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.

Authors:  Benjamin S Braun; David A Tuveson; Namie Kong; Doan T Le; Scott C Kogan; Jacob Rozmus; Michelle M Le Beau; Tyler E Jacks; Kevin M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

8.  β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells.

Authors:  Jenny Yeung; Maria Teresa Esposito; Arnaud Gandillet; Bernd B Zeisig; Emmanuel Griessinger; Dominique Bonnet; Chi Wai Eric So
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

9.  Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.

Authors:  Arnaud Gandillet; Sophie Park; François Lassailly; Emmanuel Griessinger; Jacques Vargaftig; Andrew Filby; T Andrew Lister; Dominique Bonnet
Journal:  Leukemia       Date:  2011-02-22       Impact factor: 11.528

10.  Oncogenic Kras initiates leukemia in hematopoietic stem cells.

Authors:  Amit J Sabnis; Laurene S Cheung; Monique Dail; Hio Chung Kang; Marianne Santaguida; Michelle L Hermiston; Emmanuelle Passegué; Kevin Shannon; Benjamin S Braun
Journal:  PLoS Biol       Date:  2009-03-17       Impact factor: 8.029
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.